Preventative effects of lactulose in the trinitrobenzenesulphonic acid model of rat colitis. - Wikidata - awgldk - TriplyDB

Preventative effects of lactulose in the trinitrobenzenesulphonic acid model of rat colitis.

Preventative effects of lactulose in the trinitrobenzenesulphonic acid model of rat colitis.

http://www.wikidata.org/entity/Q45285907

about

Nutritional Keys for Intestinal Barrier Modulation The Intestinal Microbiota in Inflammatory Bowel Disease Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility Epicatechin used in the treatment of intestinal inflammatory disease: an analysis by experimental models.Review article: prebiotics in the gastrointestinal tract.Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics.Probiotics and prebiotics in chronic inflammatory bowel diseases.Dietary intervention with narrow-leaved cattail rhizome flour (Typha angustifolia L.) prevents intestinal inflammation in the trinitrobenzenesulphonic acid model of rat colitis Silk fibroin nanoparticles constitute a vector for controlled release of resveratrol in an experimental model of inflammatory bowel disease in rats.Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'.Pathobiology and potential therapeutic value of intestinal short-chain fatty acids in gut inflammation and obesity.The viability of Lactobacillus fermentum CECT5716 is not essential to exert intestinal anti-inflammatory properties.The intestinal anti-inflammatory effect of dersalazine sodium is related to a down-regulation in IL-17 production in experimental models of rodent colitis Effect of a probiotic beverage consumption (Enterococcus faecium CRL 183 and Bifidobacterium longum ATCC 15707) in rats with chemically induced colitis Pathogenesis of hepatic encephalopathy: the tumour necrosis factor-alpha theory.The interplay between fiber and the intestinal microbiome in the inflammatory response.Prebiotics in inflammatory bowel diseases.Double-blind controlled randomised study of lactulose and lignin hydrolysed combination in complex therapy of atopic dermatitis.Prebiotics in chronic intestinal inflammation.Intestinal anti-inflammatory effects of RGD-functionalized silk fibroin nanoparticles in trinitrobenzenesulfonic acid-induced experimental colitis in rats.Effectiveness of a hydroxynaphthoquinone fraction from Arnebia euchroma in rats with experimental colitis Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease?The Microbiome in Visceral Medicine: Inflammatory Bowel Disease, Obesity and Beyond.Unconjugated bilirubin ameliorates the inflammation and digestive protease increase in TNBS-induced colitis.Distinct effects of Lactobacillus plantarum KL30B and Escherichia coli 3A1 on the induction and development of acute and chronic inflammation.The immunomodulatory properties of viable Lactobacillus salivarius ssp. salivarius CECT5713 are not restricted to the large intestine.Wild-type and IL10-null mice have differential colonic epithelial gene expression responses to dietary supplementation with synbiotic Bifidobacterium animalis subspecies lactis and inulin.Mediterranean Diet: Prevention of Colorectal Cancer.Analysis of β-catenin expression and exon 3 mutations in pediatric sporadic aggressive fibromatosis.Anti-Inflammatory Effects of an Extract of Polygonum hydropiper Stalks on 2,4,6-Trinitrobenzenesulphonic Acid-Induced Intestinal Inflammation in Rats by Inhibiting the NF-κB Pathway.

P2860

Q26772345-7FA02AA4-7CF2-453D-9C2C-41E739A61F0E Q26795705-1262D27F-F99A-4D3F-B239-CD7C07F8FBCA Q26995672-599559EB-63BF-429F-9F1B-8AC4A3C2460B Q30394372-3C11EB2F-D923-4E6F-916E-CD255AB2F9B1 Q33254445-47465A1A-3312-4488-ABAC-350516CA741B Q33439062-BECBC8D7-C970-4559-AED2-5EF5A63EFFD3 Q34013030-252370F7-0718-4EB5-BDEA-98116F86B0FD Q34257931-ECFF7F5A-7B9E-493C-90A2-9A2A77545286 Q34274578-3D5491EA-FC59-4913-B32F-3F072C705556 Q34588415-F0E9A32B-447A-40F6-B173-2359AFE95D6A Q35049771-CAB14A93-D0B6-44B6-A8F7-CD8FDE5A4DE7 Q35564583-F9DC6DD4-C2E8-45AB-B81E-DD7E17555970 Q35859785-9FED6A7A-A31A-4184-8A86-D7B4D3FC7992 Q36355121-F1BFB141-755B-464B-B85D-1B66D660FED1 Q36764958-4BD5B6C3-73A2-4B62-BBCE-E8C9801230B6 Q36828774-2488404F-E930-486D-BA47-47F3C11A7034 Q36965046-626F5FA8-87D1-40BE-9395-8338C90A15D9 Q37037795-EF726B71-AD0C-4171-B4AD-7B96235B77E7 Q37285115-1E386656-98B4-44F8-920C-CE5729BD0C9E Q37413157-B177058D-1F5D-4E74-8FC2-06E778A1DD2D Q37439929-49A7460F-0516-4333-A39E-F26EA1360B9D Q38268672-DCC3DA31-1C39-4216-878E-347AC4F33CBC Q38676932-509AE711-9523-45D3-BCFB-11AE546E49AD Q38705943-5D7045F1-2172-4EDA-9B10-43B465C472E4 Q41965994-C90E8A93-C50C-491C-A7B1-7D33EA29F9B9 Q44587821-A039AFFD-77C0-482F-85EB-8311D97262D4 Q44899033-C5764106-6AA7-4ADA-91AE-30C1CD1DCBDA Q47104184-9864F6E6-E1FD-4838-B499-CE5207F8DFD2 Q54387655-33AC7146-6FED-4F7B-A9A5-D6E79E7AF600 Q55002814-355026D8-9579-4862-9E51-F91043CA1D49

P2860

Preventative effects of lactulose in the trinitrobenzenesulphonic acid model of rat colitis.

http://www.wikidata.org/entity/Q45285907

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Preventative effects of lactul ...... nic acid model of rat colitis.

@en

Preventative effects of lactul ...... nic acid model of rat colitis.

@nl

type

label

Preventative effects of lactul ...... nic acid model of rat colitis.

@en

Preventative effects of lactul ...... nic acid model of rat colitis.

@nl

prefLabel

Preventative effects of lactul ...... nic acid model of rat colitis.

@en

Preventative effects of lactul ...... nic acid model of rat colitis.

@nl

P1433

Q45285907-3C99A815-A7BA-4C91-944C-EB0A666CE2CF

P1476

Q45285907-B4A3775B-E873-499D-8871-A299BC84C028

P2093

Q45285907-63C27FA5-FE47-4E42-879C-2A0078666B4B

Q45285907-6937E6F6-B15B-4CB2-BB08-0FEE5F741D4B

Q45285907-6D6E81F0-2740-4ABA-A3A3-4EC9C26EAD26

Q45285907-6EB07C46-15AB-4247-A6E3-10AE335F5368

Q45285907-752095C0-FA63-4BE7-BF62-9679A616D9A9

Q45285907-8F827384-A2B2-48C7-966B-264A893F5D77

Q45285907-91A3E3F2-34B8-4668-AE99-70148996F0D7

Q45285907-CD704301-7C42-4BDC-AEA9-A68E8ECA255A

P2860

Q45285907-279EA561-C789-402D-ABED-33B7588B6C16

Q45285907-30EB45D9-5E29-4E6E-883F-827DF1FDCDB2

Q45285907-3BDE750F-FC62-4A5B-B2CA-84479ED8FBCA

Q45285907-3CA67167-6267-4771-8469-894571114252

Q45285907-4E8B5712-337B-42BD-BC36-1B821DCDE5BD

Q45285907-5ECB8C6E-2225-4754-9BD3-2006D4D5D4E6

Q45285907-793A3C95-146E-4075-AE81-D50B1A2E5CF2

Q45285907-84FEBAFC-A98B-4F2A-8B93-E27039D5312A

Q45285907-BF9756C3-4A42-44AB-8695-56A438CE5199

Q45285907-C447F17C-B204-4BC1-A10E-F7526B62D054

P304

Q45285907-E7C7923D-BC85-4B79-8CF2-5316480448CA

P31

Q45285907-8E19A8FC-2BC8-4460-8137-40B641FF4CDF

P356

Q45285907-3BE3840B-959F-439C-AACC-F7D22B2D195E

P433

Q45285907-A952839D-836F-466E-A7CC-0126AF76FE3D

P478

Q45285907-7F2ABC18-9D01-4DA8-AE64-7355A3B2C93B

P50

Q45285907-3648987F-E6AA-49EB-94AB-7A2014BC203B

P577

Q45285907-0F1931EB-B2FB-483E-A5BC-4E487F456C75

P698

Q45285907-E245A1FE-F33C-46A4-8621-20047D0D7FCF

P921

Q45285907-F6295B8F-95BD-4CF2-857C-FEF027091DE7

P356

01.MIB.0000160808.30988.D9

P1433

Inflammatory Bowel Diseases

P1476

Preventative effects of lactul ...... nic acid model of rat colitis.

@en

P2093

Ana Nieto

http://www.w3.org/2001/XMLSchema#string

Angel Concha

http://www.w3.org/2001/XMLSchema#string

Antonio Zarzuelo

http://www.w3.org/2001/XMLSchema#string

Desiree Camuesco

http://www.w3.org/2001/XMLSchema#string

Laura Peran

http://www.w3.org/2001/XMLSchema#string

Luiz C Di Stasi

http://www.w3.org/2001/XMLSchema#string

M Elena Rodriguez-Cabezas

http://www.w3.org/2001/XMLSchema#string

Monica Comalada

http://www.w3.org/2001/XMLSchema#string

P2860

Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.

Lactulose ingestion increases faecal bifidobacterial counts: a randomised double-blind study in healthy humans.

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.

Probiotics and inflammatory bowel disease: is there a scientific rationale?

Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.

The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats

The intestinal anti-inflammatory activity of UR-12746S on reactivated experimental colitis is mediated through downregulation of cytokine production.

Chemotactic activity in inflammatory bowel disease. Role of leukotriene B4.

Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat.

Germinated barley foodstuff, a prebiotic product, ameliorates inflammation of colitis through modulation of the enteric environment.

P304

265-271

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.MIB.0000160808.30988.D9

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15735433

http://www.w3.org/2001/XMLSchema#string

P921